• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于破坏细胞膜机制的钌基金属药物的合成及抗菌活性研究。

The synthesis and antibacterial activity study of ruthenium-based metallodrugs with a membrane-disruptive mechanism against .

机构信息

Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, 330013, China.

School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, 418000, China.

出版信息

Dalton Trans. 2022 Oct 11;51(39):14980-14992. doi: 10.1039/d2dt01531e.

DOI:10.1039/d2dt01531e
PMID:36112764
Abstract

The wide spread of drug-resistant bacteria, especially methicillin-resistant (MRSA), poses a tremendous threat to global health. Of particular concern, resistance to vancomycin, linezolid, and daptomycin has already been reported in clinical MRSA strains. New antibacterial agents are urgently needed to overcome this crisis. Here, we designed and synthesized a series of ruthenium-based antibacterial agents targeting bacterial membrane integrity. Structure-activity relationship studies demonstrated that both the lipophilicity/hydrophilicity ratio and biphenyl group play an important role in elevating the antibacterial activity. To characterize the antibacterial mechanism, we combined scanning electron microscopy, propidium iodide dyeing, and DNA leakage assays. The results demonstrated that Ru2 could destroy the integrity of bacterial cell membranes. In addition, Ru2 can efficiently inhibit biofilm formation and α-hemolysin secretion from . Finally, in both a mouse skin infection model and a wax worm infection model, Ru2 showed significant antibacterial activity . Moreover, the Ru2 complex was almost non-toxic. Thus, this work demonstrated that ruthenium-based complexes bearing a biphenyl group are promising agents to combat bacterial infection.

摘要

耐药菌(尤其是耐甲氧西林金黄色葡萄球菌,MRSA)的广泛传播对全球健康构成了巨大威胁。值得特别关注的是,临床分离的 MRSA 菌株已经出现了对万古霉素、利奈唑胺和达托霉素的耐药性。急需新型抗菌药物来应对这一危机。在这里,我们设计并合成了一系列针对细菌膜完整性的基于钌的抗菌剂。构效关系研究表明,亲脂性/亲水性比和联苯基团都对提高抗菌活性起着重要作用。为了表征抗菌机制,我们结合了扫描电子显微镜、碘化丙啶染色和 DNA 泄漏实验。结果表明,Ru2 可以破坏细菌细胞膜的完整性。此外,Ru2 可以有效抑制生物膜的形成和α-溶血素从 的分泌。最后,在小鼠皮肤感染模型和黄粉虫感染模型中,Ru2 都表现出了显著的抗菌活性。而且,Ru2 配合物的毒性几乎可以忽略不计。因此,这项工作表明,含有联苯基团的基于钌的配合物是对抗细菌感染有前途的药物。

相似文献

1
The synthesis and antibacterial activity study of ruthenium-based metallodrugs with a membrane-disruptive mechanism against .基于破坏细胞膜机制的钌基金属药物的合成及抗菌活性研究。
Dalton Trans. 2022 Oct 11;51(39):14980-14992. doi: 10.1039/d2dt01531e.
2
Synthesis and biological evaluation of ruthenium complexes containing phenylseleny against Gram-positive bacterial infection by damage membrane integrity and avoid drug-resistance.合成并评价含苯硒基的钌配合物抗革兰氏阳性菌感染的活性,其作用机制为破坏细胞膜完整性和避免耐药性的产生。
J Inorg Biochem. 2023 May;242:112175. doi: 10.1016/j.jinorgbio.2023.112175. Epub 2023 Mar 3.
3
Ruthenium(II) complexes targeting membrane as biofilm disruptors and resistance breakers in Staphylococcus aureus bacteria.钌(II)配合物靶向细胞膜作为金黄色葡萄球菌生物膜破坏剂和耐药性突破剂。
Eur J Med Chem. 2022 Aug 5;238:114485. doi: 10.1016/j.ejmech.2022.114485. Epub 2022 May 21.
4
Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate and Staphylococcal Skin Infection.载蜂毒素的非离子表面活性剂囊泡对抗耐万古霉素中间型葡萄球菌和葡萄球菌皮肤感染的潜力。
Int J Nanomedicine. 2021 Nov 16;16:7639-7661. doi: 10.2147/IJN.S325901. eCollection 2021.
5
Ru-Based Organometallic Agents Bearing Phenyl Hydroxide: Synthesis and Antibacterial Mechanism Study against Staphylococcus aureus.基于钌的有机金属试剂带有苯羟基:对金黄色葡萄球菌的合成及抗菌机制研究。
ChemMedChem. 2023 Oct 4;18(19):e202300306. doi: 10.1002/cmdc.202300306. Epub 2023 Sep 1.
6
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.2008 年至 2011 年,美国医院检测到对利奈唑胺、达托霉素或万古霉素敏感性降低的葡萄球菌的抗菌活性。
Antimicrob Agents Chemother. 2013 Jul;57(7):3178-81. doi: 10.1128/AAC.00484-13. Epub 2013 Apr 29.
7
Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.在体外药效学模型中观察到利奈唑胺对达托霉素或万古霉素抗生物膜形成耐甲氧西林金黄色葡萄球菌活性的拮抗作用。
Antimicrob Agents Chemother. 2015 Dec;59(12):7790-4. doi: 10.1128/AAC.01604-15. Epub 2015 Sep 14.
8
Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.达托霉素与万古霉素治疗实验性兔耐甲氧西林金黄色葡萄球菌性脑膜炎的比较。
Antimicrob Agents Chemother. 2013 Mar;57(3):1556-8. doi: 10.1128/AAC.01996-12. Epub 2013 Jan 14.
9
Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.达托霉素、利奈唑胺、万古霉素或甲氧西林中介或耐药金黄色葡萄球菌的达氟沙星活性。
J Antimicrob Chemother. 2020 Sep 1;75(9):2605-2608. doi: 10.1093/jac/dkaa209.
10
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.头孢洛林对耐甲氧西林金黄色葡萄球菌(MRSA)中达托霉素、利奈唑胺或万古霉素低水平耐药株,以及具有明确 SCCmec 型别的菌株的活性。
Int J Antimicrob Agents. 2014 Apr;43(4):323-7. doi: 10.1016/j.ijantimicag.2013.11.005. Epub 2013 Dec 11.

引用本文的文献

1
The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs.医学的弃儿:医学中的金属——从传统矿物药到金属药物
Front Pharmacol. 2025 Apr 7;16:1542560. doi: 10.3389/fphar.2025.1542560. eCollection 2025.
2
Application of a modified multifunctional short peptide in the treatment of periodontitis.改性多功能短肽在牙周炎治疗中的应用。
Sci Rep. 2024 Oct 1;14(1):22855. doi: 10.1038/s41598-024-69933-z.
3
Ruthenium(II) Polypyridyl Complexes and Metronidazole Derivatives: A Powerful Combination in the Design of Photoresponsive Antibacterial Agents Effective under Hypoxic Conditions.
钌(II)多吡啶配合物和甲硝唑衍生物:设计在缺氧条件下具有光响应抗菌活性的药物的有力组合。
Inorg Chem. 2023 May 22;62(20):7716-7727. doi: 10.1021/acs.inorgchem.3c00214. Epub 2023 May 10.
4
Biological Activities of Ruthenium NHC Complexes: An Update.钌氮杂环卡宾配合物的生物活性:最新进展。
Antibiotics (Basel). 2023 Feb 9;12(2):365. doi: 10.3390/antibiotics12020365.
5
Flourishing Antibacterial Strategies for Osteomyelitis Therapy.蓬勃发展的骨髓炎治疗抗菌策略。
Adv Sci (Weinh). 2023 Apr;10(11):e2206154. doi: 10.1002/advs.202206154. Epub 2023 Jan 30.